Effectiveness and cost-effectiveness of guided Internet- and mobile-based CBT for adolescents and young adults with chronic somatic conditions and comorbid depression and anxiety symptoms (youthCOACH
Adolescent
Anxiety
/ therapy
Chronic Disease
/ psychology
Cognitive Behavioral Therapy
/ methods
Cost-Benefit Analysis
Depression
/ therapy
Humans
Internet-Based Intervention
Multicenter Studies as Topic
Patient Health Questionnaire
Quality of Life
Randomized Controlled Trials as Topic
Treatment Outcome
Young Adult
AYA
Anxiety
Chronic somatic conditions
Depression
Internet- and mobile-based interventions
RCT
Journal
Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253
Informations de publication
Date de publication:
12 Mar 2020
12 Mar 2020
Historique:
received:
11
09
2019
accepted:
30
12
2019
entrez:
14
3
2020
pubmed:
14
3
2020
medline:
29
12
2020
Statut:
epublish
Résumé
Adolescents and young adults (AYA) with chronic somatic conditions have an increased risk of comorbid depression and anxiety symptoms. Internet- and mobile-based cognitive behavioural therapy (iCBT) might be one possibility to extend the access to evidence-based treatments. Studies suggest that guided iCBT can reduce anxiety and depression symptoms in AYA. However, little is known about the effectiveness of iCBT for AYA with chronic somatic conditions and comorbid symptoms of anxiety and/or depression in routine care. Evidence on the (cost-)effectiveness of iCBT is essential for its implementation in health care. This multicentre two-armed randomized controlled trial (RCT) aims to evaluate the (cost-) effectiveness of guided iCBT (youthCOACH iCBT might implicate novel ways to increase the access to evidence-based interventions in this specific population. The distinct focus on effectiveness and cost-effectiveness of youthCOACH German Clinical Trials Register (DRKS), DRKS00017161. Registered on 17 September 2019.
Sections du résumé
BACKGROUND
BACKGROUND
Adolescents and young adults (AYA) with chronic somatic conditions have an increased risk of comorbid depression and anxiety symptoms. Internet- and mobile-based cognitive behavioural therapy (iCBT) might be one possibility to extend the access to evidence-based treatments. Studies suggest that guided iCBT can reduce anxiety and depression symptoms in AYA. However, little is known about the effectiveness of iCBT for AYA with chronic somatic conditions and comorbid symptoms of anxiety and/or depression in routine care. Evidence on the (cost-)effectiveness of iCBT is essential for its implementation in health care.
OBJECTIVES AND METHODS
OBJECTIVE
This multicentre two-armed randomized controlled trial (RCT) aims to evaluate the (cost-) effectiveness of guided iCBT (youthCOACH
DISCUSSION
CONCLUSIONS
iCBT might implicate novel ways to increase the access to evidence-based interventions in this specific population. The distinct focus on effectiveness and cost-effectiveness of youthCOACH
TRIAL REGISTRATION
BACKGROUND
German Clinical Trials Register (DRKS), DRKS00017161. Registered on 17 September 2019.
Identifiants
pubmed: 32164723
doi: 10.1186/s13063-019-4041-9
pii: 10.1186/s13063-019-4041-9
pmc: PMC7069009
doi:
Types de publication
Clinical Trial Protocol
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
253Subventions
Organisme : German Ministriy of Education and Research
ID : 01GL1740A; 01GL1740E
Références
J Affect Disord. 2018 Jan 1;225:733-755
pubmed: 28922737
J Affect Disord. 2017 Dec 1;223:28-40
pubmed: 28715726
Qual Life Res. 2010 Aug;19(6):875-86
pubmed: 20405245
Int J Methods Psychiatr Res. 2018 Sep;27(3):e1610
pubmed: 29465165
PLoS One. 2013 Aug 13;8(8):e70567
pubmed: 23967077
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Dtsch Arztebl Int. 2018 Nov 5;115(40):659-665
pubmed: 30381130
Qual Life Res. 2010 Aug;19(6):887-97
pubmed: 20401552
Eur Child Adolesc Psychiatry. 2015 Jun;24(6):705-13
pubmed: 25651821
Z Kinder Jugendpsychiatr Psychother. 2018 Jan;46(1):47-56
pubmed: 28117627
Semin Arthritis Rheum. 2017 Oct;47(2):269-275
pubmed: 28583690
Depress Anxiety. 2019 Mar;36(3):213-224
pubmed: 30450811
Gen Hosp Psychiatry. 2016 Mar-Apr;39:24-31
pubmed: 26719105
Arthritis Rheum. 1994 Dec;37(12):1761-9
pubmed: 7986222
J Behav Ther Exp Psychiatry. 2002 Mar;33(1):1-18
pubmed: 12389796
Nervenarzt. 2007 Jun;78(6):651-6
pubmed: 16832698
J Pers. 1996 Mar;64(1):71-105
pubmed: 8656319
Acta Paediatr. 2011 Aug;100(8):1069-76
pubmed: 21332786
J Pediatr Psychol. 2009 Jan-Feb;34(1):79-88
pubmed: 18522995
Curr Opin Pulm Med. 2011 Nov;17(6):473-7
pubmed: 21881513
Clin Psychol Psychother. 2016 May;23(3):217-25
pubmed: 25772711
BMJ. 2010 Mar 23;340:c332
pubmed: 20332509
Front Psychol. 2014 Nov 11;5:1256
pubmed: 25426088
Dtsch Arztebl Int. 2017 Oct 13;114(41):681-688
pubmed: 29082858
Annu Rev Clin Psychol. 2016;12:157-79
pubmed: 26652054
Pharmacoeconomics. 2018 May;36(5):509-522
pubmed: 29427072
Clin Psychol Rev. 2012 Jun;32(4):329-42
pubmed: 22466510
J Am Acad Child Adolesc Psychiatry. 1999 Oct;38(10):1230-6
pubmed: 10517055
J Med Internet Res. 2016 Aug 31;18(8):e234
pubmed: 27582341
Depress Anxiety. 2004;20(4):155-64
pubmed: 15643639
JAMA. 2007 Jun 27;297(24):2741-51
pubmed: 17595275
Pediatr Rheumatol Online J. 2016 Apr 18;14(1):23
pubmed: 27089922
Psychosom Med. 2016 Jul-Aug;78(6):716-27
pubmed: 27187854
Cochrane Database Syst Rev. 2011 Sep 07;(9):CD008012
pubmed: 21901717
J Pediatr Psychol. 2004 Dec;29(8):635-40
pubmed: 15491986
Eur J Health Econ. 2016 Apr;17 Suppl 1:7-18
pubmed: 27059622
Br J Psychiatry Suppl. 2000;(39):s28-33
pubmed: 10945075
Value Health. 2019 Jan;22(1):31-37
pubmed: 30661631
Psychiatr Serv. 2014 Mar 1;65(3):359-66
pubmed: 24233052
Expert Rev Pharmacoecon Outcomes Res. 2012 Dec;12(6):745-64
pubmed: 23252357
World Psychiatry. 2014 Feb;13(1):4-11
pubmed: 24497236
Psychiatr Prax. 2001 Oct;28 Suppl 2:S84-90
pubmed: 11605129
BMJ. 2010 Mar 23;340:c869
pubmed: 20332511
Int J Psychiatry Clin Pract. 2012 Jun;16(2):77-84
pubmed: 22540422
Cogn Behav Ther. 2011;40(2):82-97
pubmed: 25155812
J Pediatr Psychol. 2011 May;36(4):375-84
pubmed: 21088072
Behav Ther. 2015 Mar;46(2):206-17
pubmed: 25645169
Cogn Behav Ther. 2011;40(3):216-27
pubmed: 21770844
Eur J Health Econ. 2016 Apr;17 Suppl 1:79-87
pubmed: 27086322
J Am Acad Child Adolesc Psychiatry. 1997 Apr;36(4):545-53
pubmed: 9100430
J Diabetes Sci Technol. 2016 Aug 22;10(5):1042-9
pubmed: 27381028
BMC Pulm Med. 2014 Dec 16;14:205
pubmed: 25515072
J Child Psychol Psychiatry. 2006 Sep;47(9):927-34
pubmed: 16930387
Lancet. 2008 Jul 19;372(9634):246-55
pubmed: 18640461
Curr Opin Psychiatry. 2012 Sep;25(5):405-14
pubmed: 22801356
Health Econ. 2016 Jun;25(6):768-77
pubmed: 25926161
J Clin Psychol Med Settings. 2015 Mar;22(1):20-44
pubmed: 25666485
Cochrane Database Syst Rev. 2018 Aug 15;8:CD012489
pubmed: 30110718
J Cyst Fibros. 2008 Sep;7(5):450-3
pubmed: 18442953
Psychol Med. 2016 Oct;46(13):2679-93
pubmed: 27649340
Ann Intern Med. 2013 Feb 5;158(3):200-7
pubmed: 23295957
J Am Acad Child Adolesc Psychiatry. 2014 Dec;53(12):1254-1270.e5
pubmed: 25457924
J Affect Disord. 2017 Mar 01;210:189-195
pubmed: 28049104
Cogn Behav Ther. 2018 Jan;47(1):1-18
pubmed: 29215315
Pediatrics. 2010 Dec;126(6):1117-23
pubmed: 21041282
J Rheumatol. 2002 Mar;29(3):622-8
pubmed: 11908581
J Am Acad Child Adolesc Psychiatry. 1988 Nov;27(6):726-37
pubmed: 3058677
Clin Psychol Psychother. 2010 May-Jun;17(3):231-9
pubmed: 20013760
Ann Behav Med. 2015 Aug;49(4):579-93
pubmed: 25690370
Behav Res Ther. 2014 Aug;59:20-9
pubmed: 24949908
Epilepsy Behav. 2017 Feb;67:45-50
pubmed: 28088680
Internet Interv. 2016 Jun 27;5:1-4
pubmed: 30135800
Z Kinder Jugendpsychiatr Psychother. 2020 Jan;48(1):33-46
pubmed: 30422059
J Rheumatol. 2010 Jul;37(7):1534-41
pubmed: 20551105
Am J Psychiatry. 2011 Oct;168(10):1066-74
pubmed: 21676990
J Am Acad Child Adolesc Psychiatry. 2004 Aug;43(8):930-59
pubmed: 15266189
PLoS One. 2015 Mar 18;10(3):e0119895
pubmed: 25786025
Nat Rev Neurosci. 2008 Oct;9(10):788-96
pubmed: 18784657